Angela Land
Primary Care · Gainesville, FLNPI 1326431438
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $630 and has fallen 88.8% since, to $70 in 2024.
Across 69 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$242
- Novo Nordisk$147
- GSK$130
- Boehringer Ingelheim$117
- Vanda Pharmaceuticals Inc.$77
- AstraZeneca$54
- plus $408 from 15 others
What the payments were for
- Food & beverage$1,176100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 18 | $242 |
| Novo Nordisk | 10 | $147 |
| GSK | 7 | $130 |
| Boehringer Ingelheim | 5 | $117 |
| Vanda Pharmaceuticals Inc. | 3 | $77 |
| AstraZeneca | 4 | $54 |
| Xeris Pharmaceuticals, Inc. | 2 | $48 |
| Johnson & Johnson | 3 | $43 |
| Merck | 2 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| Organogenesis Inc. | 2 | $37 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Boston Scientific | 1 | $26 |
| Novartis | 1 | $22 |
| AbbVie | 1 | $21 |
| Pfizer | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Abbott | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $16 |
| Upsher-smith Laboratories LLC | 1 | $13 |
How this compares
$1,176 in reported general payments places this provider in the 70th percentile of 725 primary care providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 18 | $412 |
| Metoprolol Succinate | 16 | $295 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $239 |
| Atorvastatin Calcium | 18 | $210 |
| Losartan Potassium | 13 | $147 |
| Levothyroxine Sodium | 14 | $142 |
| Metformin Hcl | 12 | $135 |
Paid to pharmacies, not to this prescriber.
Other primary care in Gainesville
- Kristin KayGainesville$6K
- Melissa CobbGainesville$4K
- Paul ChanOrlando$447K
- Jenny WestPensacola$80K
- Railet RodriguezAltamonte Springs$14K
- Kevin HanawayFort Lauderdale$12K
- Kelly ChewningAlachua$11K
- Yolanda PalmeroSaint Cloud$11K
- Erica ClarkCitrus Springs$11K
- Michelle SelvaggiLakewood Ranch$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.